Alan Boyd
- Genetics top 2%
- Bacterial Genetics and Biotechnology 13
- Virus-based gene therapy research 9
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 9
- CRISPR and Genetic Engineering 6
- Endocrinology top 5%
- Cell Biology top 5%
- Cellular transport and secretion 10
-
- Cystic Fibrosis Research Advances 12
- Neonatal Respiratory Health Research 12
-
- Viral gastroenteritis research and epidemiology 7
- Co-authors
- Melvin I. SimonMichael J. R. StarkDavid J. PorteousI. Barry HollandNorihiro MutohLeonora F. CiufoNia J. BryantJ. Alastair Innes
- Journals
- Journal of Cystic Fibrosis (6 papers)Epilepsy & Behavior (4 papers)Nucleic Acids Research (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Alan Boyd
69 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 130
- Genetics 806
- Molecular Biology 1.8k
- Endocrinology 108
- Cell Biology 344
- Pulmonary and Respiratory Medicine 405
Countries citing papers authored by Alan Boyd
This map shows the geographic impact of Alan Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Boyd more than expected).
Fields of papers citing papers by Alan Boyd
This network shows the impact of papers produced by Alan Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Boyd. The network helps show where Alan Boyd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 17 | |
| 4 | 2022 | 40 | |
| 5 | 2021 | 18 | |
| 6 | 2016 | 36 | |
| 7 | 2015 | 40 | |
| 8 | LARGE-SCALE PRODUCTION OF LENTIVIRAL VECTORS FOR CF LUNG GENE THERAPY | 2014 | 1 |
| 9 | 2012 | 79 | |
| 10 | 2010 | 6 | |
| 11 | 2008 | 2 | |
| 12 | 2008 | 36 | |
| 13 | 2006 | 89 | |
| 14 | Development of sputum calprotectin as a biomarker of cystic fibrosis lung disease activity: Evidence from cross sectional and longitudinal studies | 2006 | 1 |
| 15 | Sputum metal ions are biomarkers for suppurative and inflammatory lung disease | 2006 | 0 |
| 16 | 2004 | 4 | |
| 17 | 2000 | 45 | |
| 18 | 1997 | 20 | |
| 19 | 1992 | 5 | |
| 20 | 1989 | 58 |
About Alan Boyd
Alan Boyd is a scholar working on Genetics, Issues, ethics and legal aspects and Cell Biology, having authored 72 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (13 papers), Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (12 papers), Cellular transport and secretion (10 papers), Virus-based gene therapy research (9 papers), RNA and protein synthesis mechanisms (9 papers), Viral gastroenteritis research and epidemiology (7 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Genetics (806 citations), Molecular Biology (1.8k citations) and Endocrinology (108 citations). Alan Boyd has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Melvin I. Simon, Michael J. R. Stark, David J. Porteous, I. Barry Holland, Norihiro Mutoh, Leonora F. Ciufo, Nia J. Bryant, J. Alastair Innes, David J. Sherratt and R. R. Duncan. Their work appears in journals such as Journal of Cystic Fibrosis, Epilepsy & Behavior, Nucleic Acids Research, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.